Chosa Oncology AB (XSAT:CHOSA) EBITDA Margin %: 0.00% (As of Mar. 2026)


XSAT:CHOSA Chosa Oncology AB XSAT:CHOSA
30 GF Score
Price kr0.83
View Full Analysis

What is Chosa Oncology AB EBITDA Margin %?

Chosa Oncology AB XSAT:CHOSA 30 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates XSAT:CHOSA with a GF Score™ of 30/100. Among 944 Biotechnology companies, Chosa Oncology AB ranks worse than 105932.1% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Chosa Oncology AB's EBITDA for the three months ended in Mar. 2026 was kr-1.87 Mil. Chosa Oncology AB's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Chosa Oncology AB's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.

Chosa Oncology AB  (XSAT:CHOSA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Chosa Oncology AB EBITDA Margin % Related Terms

Chosa Oncology AB EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Chosa Oncology AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB EBITDA Margin % Chart

Chosa Oncology AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Chosa Oncology AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XSAT:CHOSA vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Chosa Oncology AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chosa Oncology AB EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chosa Oncology AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Chosa Oncology AB's EBITDA Margin % falls into.


XSAT:CHOSA
30GF Score
Chosa Oncology AB XSAT:CHOSA
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chosa Oncology AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Chosa Oncology AB's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.89/0
= %

Chosa Oncology AB's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.866/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Chosa Oncology AB (XSAT:CHOSA) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chosa Oncology AB and its competitors. According to the industry distribution chart, Chosa Oncology AB ranks #999999 out of 944 companies in the Biotechnology industry.
Is Chosa Oncology AB's EBITDA Margin % too high?
Chosa Oncology AB's current EBITDA Margin % is 0.00%. Based on the distribution chart, Chosa Oncology AB ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chosa Oncology AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chosa Oncology AB ranks #999999 out of 944 companies for EBITDA Margin %. This places Chosa Oncology AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chosa Oncology AB and its competitors. Chosa Oncology AB's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (XSAT:CHOSA) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Chosa Oncology AB's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Chosa Oncology AB (XSAT:CHOSA), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chosa Oncology AB Business Description

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
30GF Score

Get the complete analysis for XSAT:CHOSA

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.83
Price